<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="101372">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01784822</url>
  </required_header>
  <id_info>
    <org_study_id>12-013</org_study_id>
    <nct_id>NCT01784822</nct_id>
  </id_info>
  <brief_title>Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair</brief_title>
  <official_title>Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <brief_summary>
    <textblock>
      The objective this study is to collect post-market data on the performance of the Zenapro™
      Hybrid Hernia Repair Device when used to reinforce or bridge the abdominal wall for the
      repair of ventral hernias.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of hernia recurrence</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Ventral Hernias</condition>
  <arm_group>
    <arm_group_label>Zenapro™ Hybrid Hernia Repair Device</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Device to be used to reinforce or bridge the abdominal wall for the repair of ventral hernias.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zenapro™ Hybrid Hernia Repair Device</intervention_name>
    <description>Device will be placed during open or laparoscopic hernia repair.</description>
    <arm_group_label>Zenapro™ Hybrid Hernia Repair Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary or recurrent ventral hernia

          -  Need for abdominal wall repair with reinforcement or bridging material to obtain the
             desired surgical result

        Exclusion Criteria:

          -  Age &lt; 21 (i.e., infants, children)

          -  Device intended to be used in an infected wound

          -  Known sensitivity to porcine material

          -  Pregnant or planning pregnancy in the future

          -  Life expectancy of less than 12 months from the date of the index procedure

          -  Hernia too large to be covered with a single device with at least 4-5 cm of tissue
             overlap on all sides
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Tennessee</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 7, 2017</lastchanged_date>
  <firstreceived_date>February 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ventral hernia</keyword>
  <keyword>Graft repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
